NCT05653479View on ClinicalTrials.gov

Safety and Blood Levels After a Single Injection of UPB-101 in Healthy Japanese and Non-Japanese Non-East Asian Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

December 5, 2022

Primary Completion Date

April 7, 2023

Study Completion Date

May 13, 2023

Conditions

Healthy

Interventions

DRUG

UPB-101

UPB-101 Subcutaneous injection

Trial Locations (1)

Unknown

Richmond Pharmacology, London

All Listed Sponsors

lead

Upstream Bio Inc.

INDUSTRY